BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34363022)

  • 1. FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC/STAT3 signaling axis in ovarian cancer.
    Li H; Qi Z; Niu Y; Yang Y; Li M; Pang Y; Liu M; Cheng X; Xu M; Wang Z
    Oncogene; 2021 Oct; 40(40):5938-5949. PubMed ID: 34363022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose-1,6-bisphosphatase loss modulates STAT3-dependent expression of PD-L1 and cancer immunity.
    Wang B; Zhou Y; Zhang J; Jin X; Wu H; Huang H
    Theranostics; 2020; 10(3):1033-1045. PubMed ID: 31938049
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
    Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3.
    Xiong X; Lai X; Zhang J; Meng Q; Wang P; Qin S; Liu W; Wang Y; Yao Z; Wang D; Li X; Liu Z; Miao H
    Biosci Rep; 2022 Sep; 42(9):. PubMed ID: 36000567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fructose-1,6-bisphosphatase is a novel regulator of Wnt/β-Catenin pathway in breast cancer.
    Li K; Ying M; Feng D; Du J; Chen S; Dan B; Wang C; Wang Y
    Biomed Pharmacother; 2016 Dec; 84():1144-1149. PubMed ID: 27780144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.
    Jia Y; Shi H; Cao Y; Feng W; Li M; Li X
    Life Sci; 2019 Sep; 233():116715. PubMed ID: 31376371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
    Zhao W; Yang S; Chen J; Zhao J; Dong J
    Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.
    Lu C; Ren C; Yang T; Sun Y; Qiao P; Wang D; Lv S; Yu Z
    Mol Cancer Res; 2020 May; 18(5):787-796. PubMed ID: 32041737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
    Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
    Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.
    Lu C; Ren C; Yang T; Sun Y; Qiao P; Han X; Yu Z
    Theranostics; 2020; 10(19):8606-8618. PubMed ID: 32754266
    [No Abstract]   [Full Text] [Related]  

  • 11. Fructose‑1,6‑bisphosphatase‑1 decrease may promote carcinogenesis and chemoresistance in cervical cancer.
    Li H; Li M; Pang Y; Liu F; Sheng D; Cheng X
    Mol Med Rep; 2017 Dec; 16(6):8563-8571. PubMed ID: 28990097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
    Zhang P; Shao Y; Quan F; Liu L; Yang J
    Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
    Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
    Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.
    Escalona RM; Bilandzic M; Western P; Kadife E; Kannourakis G; Findlay JK; Ahmed N
    BMC Cancer; 2020 Oct; 20(1):960. PubMed ID: 33023532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction.
    Jin X; Pan Y; Wang L; Ma T; Zhang L; Tang AH; Billadeau DD; Wu H; Huang H
    Cancer Res; 2017 Aug; 77(16):4328-4341. PubMed ID: 28720574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells.
    Zhang J; Wang J; Xing H; Li Q; Zhao Q; Li J
    Mol Cell Biochem; 2016 Jan; 411(1-2):331-40. PubMed ID: 26546081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.
    Han Z; Hong Z; Gao Q; Chen C; Hao Z; Ji T; Hu W; Yan Y; Feng J; Liao S; Wu P; Wang D; Wang S; Zhou J; Ma D
    Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma.
    Liu GM; Li Q; Zhang PF; Shen SL; Xie WX; Chen B; Wu J; Hu WJ; Huang XY; Peng BG
    Cell Death Dis; 2018 Nov; 9(11):1132. PubMed ID: 30429463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.
    Liu X; Wang X; Zhang J; Lam EK; Shin VY; Cheng AS; Yu J; Chan FK; Sung JJ; Jin HC
    Oncogene; 2010 Jan; 29(3):442-50. PubMed ID: 19881551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.